Review article: Prevention of postsurgical relapse and recurrence in Crohn's disease

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 17, Issue 2, 2003, Pages 38-42

  Cottone, M ^a   Orlando, A ^a   Viscido, A ^a   Calabrese, E ^a   Camma C ^a   Casa A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; BUDESONIDE; IMMUNOSUPPRESSIVE AGENT; MERCAPTOPURINE; MESALAZINE; METRONIDAZOLE; ORNIDAZOLE; PROBIOTIC AGENT;

CLINICAL TRIAL; CONFERENCE PAPER; CROHN DISEASE; DRUG SCREENING; ENDOSCOPY; HUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; RELAPSE; RISK FACTOR; SIDE EFFECT; SMOKING;

ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BUDESONIDE; CROHN DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MESALAMINE; METRONIDAZOLE; ORNIDAZOLE; PROBIOTICS; RECURRENCE; RISK FACTORS; SMOKING;

EID: 0037560081     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn's disease. Gastroenterol 1990; 99: 956-63.
2. Sandborn WJ, Feagan BG, Hanauer SB, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterol 2002; 122: 512-30.
3. Cottone M, Rosselli M, Giunta M, Camma C. Tobacco and inflammatory bowel disease: epidemiology and influence of IBD evolution. Research and Clinical Forums 1998; 18(9): 1-7.
4. Cosnes J, Carbonnel F, Beaugerie L, et al. Effect of cigarette smoking on the long term course of Crohn's disease. Gastroenterol 1996; 110: 424-31.
5. Cottone M, Rosselli M, Orlando A, et al. Smoking habit and recurrence in Crohn's Disease. Gastroenterol 1994; 106: 643-8.
6. Breur-Katschnsky BD, Hollander N, Goebell H. Effect of cigarette smoking on the course of Crohn's disease. European J Gastroent Hepatol 1996; 8: 225-8.
7. Sutherland LR, Ramcharan S, Bryant H, Fick G. Effect of cigarette smoking on recurrence of Crohn's disease. Gastronterol 1990; 98: 123-8.
8. Lindberg E, Jarnerot G, Huitfeldt B. Smoking in Crohn's disease: effect on localisation and clinical course. Gut 1992; 33: 779-82.
9. Camma C, Viscido A, Latella G. et al. Mesalamine in the prevention of clinical and endoscopic postoperative recurrence of Crohn's disease: a meta-analysis Dig Liver Dis 2002; 34(Suppl. 1): A86. (Abstract)
10. Cottone M, Cammà C. Mesalamine and relapse prevention in Crohn's disease. Gastroenterol 2000; 118: 597.
11. Cammà C, Giunta M, Rosselli M, Cottone M. 5-aminosalicilyc acid in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables. Gastroenterol 1997; 113: 1465-73.
12. Caprilli R, Tonelli F, Cottone M. et al. Two mesalamine regimens in the prevention of postoperative recurrence of Crohn's disease: a pragmatic double-blind randomised controlled trial. Aliment Pharmacol Ther 2003; 17: 217-23.
13. Rutgeerts P, Hiele M, Geboes K, et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterol 1995; 108: 1617-21.
14. Rutgeerts P, Van Assche G, D'Haens G, et al. Ornidazol for prophylaxis of postoperative Crohn's disease: final results of a double-blind placebo-controlled trial. Gastroenterol 2002; 122: A666. (Abstracts)
15. Korelitz B, Hanauer S, Rutgeerts P, Present D, Peppercorn M. Post-operative prophylaxis with 6-MP, 5-ASA or placebo in Crohn's disease: a 2 year multicenter trial. Gastroenterol 1998; 114: A1011.
16. Nos P, Hinojosa J, Aguilera V, et al. Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease. Gastroenterol Hepatol 2000; 23: 374-8.
17. Greenberg GR, Feagan BG, Martin F. et al. Oral budesonide for active Crohn's disease. N Engl J Med 1994; 13: 836-41.
18. Ecker KW, Otto HF. Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn's disease: a multicentre randomized placebo-controlled trial. German Budsonide Study Group. Eur J Gastroenterol Hepatol 1999; 11: 277-82.
19. Hellers G, Cortot A, Jewell D, et al. Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group. Gastroenterol 1999; 116: 294-300.
20. Malchow HA, Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease? J Clin Gastroenterol 1997; 25: 653-8.
21. Guslandi M, Mezzi G, Sorghi M. et al. Saccharomicyces bourlardi in maintenance treatment of Crohn's disease. Dig Dis Sci 2000; 45: 1462-4.
22. Campieri M, Rizzello F, Venturi A, et al. Combination of antibiotics and probiotics treatment is efficaious in prophylaxis of post-operative recurrence of Crohn's disease; a randomized controlled study vs. mesalamine. Gastroenterol 2000; 118: A781. (Abstract)
23. Prantera C, Scribano ML, Falasco G, Andreoli A, Luzi C. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG. Gut 2002; 51: 405-9.
24. Rampton DS, Crohn's disease recurrence can be prevented after ileal resection. Gut 2002; 51: 153-4.
25. Rutgeerts P. Crohn's disease recurrence can be prevented after ileal resection. Gut 2002; 51: 152-3.